Plant Advanced Technologies

Equities

ALPAT

FR0010785790

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 09:05:24 17/05/2024 pm IST			5-day change	1st Jan Change
15 ^EUR	-1.32%		+4.90%	+77.51%

09/01	Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy	CI
2023	Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Plant Advanced Technologies SA announced that it has received funding from Clariant AG

November 29, 2019

Plant Advanced Technologies SA (ENXTPA:ALPAT) announced that it has received an equity round of funding from new investor Clariant AG (SWX:CLN) on November 29, 2019. The investor has acquired 10% stake in the company.

Latest news about Plant Advanced Technologies

Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy	09/01	CI
Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Global markets live: Warner, Givaudan, Apple, Tesla, AMC...	04/23/04
Global markets live: Haleon, Best Buy, Macy's, HSBC, GSK...	02/23/02
Plant Advanced Technologies SA Reports Earnings Results for the Half Year Ended June 30, 2022	02/22/02	CI
Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Plant Advanced Technologies SA Reports Earnings Results for the Half Year Ended June 30, 2021	31/21/31	CI
Global markets live: BNP Paribas, Ubisoft, Amazon, Chevron, Coca-Cola...	29/21/29
Plant Advanced Technologies SA Reports Consolidated Earnings Results for the Year Ended December 31, 2020	17/21/17	CI
Plant Advanced Technologies Sa Announces Financial Results for the Year Ended December 31, 2020	05/21/05	CI
Global markets live: Verizon, Pandora, HelloFresh...	04/21/04
Plant Advanced Technologies PAT Announces the Discovery of a New Class of Plant Enzymes, Published in Exclusivity in the Scientific Journal, PNAS(1), in Partnership With Kyoto University and the University of Lorraine	03/21/03	CI
Plant Advanced Technologies SA Announces Revenue Results for the Year 2020	15/21/15	CI
Plant Advanced Technologies SA Provides Revenue Guidance for the Year 2021	15/21/15	CI
CO2 GRO Inc. Announces a Commercial Feasibility with Plant Advanced Technologies PAT in France in Conjunction with Rika Biotech	28/21/28	CI
Temisis Therapeutics announced that it has received €1.6 million in funding from Financiere Hoche Bains-Les-Bains SA, Plant Advanced Technologies SA	18/20/18	CI
Plant Advanced Technologies Announces Creation of Subsidiary Cellengo	06/20/06	CI
Plant Advanced Technologies : Clariant and Plant Advanced Technologies agree strategic partnership in cosmetics	29/19/29	RE
Plant Advanced Technologies SA announced that it has received funding from Clariant AG	29/19/29	CI
Plant Advanced Technologies SA announced that it has received funding from FLC - ILP - Sadepar Gestion and other investors	26/18/26	CI
Plant Advanced Technologies Announces Board Appointments	02/18/02	CI
Plant Advanced Technologies SA Reports Unaudited Sales Results for the First Half Ended June 30, 2018	25/18/25	CI
Plant Advanced Technologies PAT Announces New Distribution Agreement with Safic-Alcan	12/18/12	CI
Plant Advanced Technologies Announces Creation of TEMISIS Subsidiary	09/18/09	CI
Plant Advanced Technologies SA announced that it has received €0.5 million in funding from Vetoquinol SA	13/17/13	CI

Chart Plant Advanced Technologies

Duration

Period

More charts

Company Profile

Plant Advanced Technologies specializes in the identification, optimization and production of rare biomolecules for the pharmaceutical laboratories, cosmetic industries and green chemistry. The group has developed revolutionary production methods based on aeroponics growing plant (soilless). Innovative technologies (PAT plantes à traire - Patent INRA-University of Lorraine / INPL and PAT Friday) allow the identification of new rare molecules previously inaccessible and the industrial production.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Ratings for Plant Advanced Technologies

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15 EUR

Average target price

11.5 EUR

Spread / Average Target

-23.33%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PLANT ADVANCED TECHNOLOGIES	+77.51%	17.89M
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research